The device, called the unidose liquid system, is the first and only nasal treatment for patients with epilepsy. A plunger on the bottom of the device releases a drug into a patients’ nostril, which is quickly absorbed by the nasal mucosa.
The device can be used during or after a seizure and can be administered by people who are not healthcare professionals. Aptar’s subsidiary, Noble International, made a training device to teach caregivers how to use the system.
Read the full article here.
More articles on supply chain:
Walgreens, Kroger form GPO
Abbott warns of 2 potential safety issues with its heart implant
Edwards Lifesciences predicts $5B in revenue in 2020
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
